CA
NZ
UK
AU
IND
US
Morgan Stanley Finance LLC has filed a preliminary pricing supplement for a new structured investment product: Jump Notes with an auto-callable feature due August 10, 2029. The notes, issued on behalf of Morgan Stanley Finance LLC and guaranteed by Morgan Stanley, are linked to …
David K. Boyer Jr., a director at Truist Financial Corp., executed a sale of 3,986 common shares on July 23, 2026, at a price of $50.70 per share, according to a regulatory filing disclosed on July 27, 2026. Following the transaction, Boyer's direct beneficial …
Bank of Montreal has issued $1.1 million in Trigger Callable Contingent Yield Notes due July 28, 2031, linked to the Russell 2000 Index, S&P 500 Index, and EURO STOXX 50 Index. The notes, which carry substantial downside risk, were priced on July 20, 2026, …
Patrick E. Bowe, a director of Andersons Inc. (NASDAQ: ANDE), sold 3,534 shares of common stock on July 22, 2026, at a price of $80.53 per share, according to a regulatory disclosure filed with the Securities and Exchange Commission on July 27, 2026. Following …
Frederic J. Winssinger, a director at USANA Health Sciences Inc., acquired 1,632 shares of common stock on July 23, 2026, through the vesting of restricted stock units, according to a regulatory disclosure filed July 27, 2026. The transaction brings Winssinger's direct beneficial ownership to …
USANA Health Sciences Inc. disclosed that Timothy E. Wood, a director of the company, acquired 1,632 shares of common stock and 1,632 restricted stock units on July 23, 2026. The transaction, reported through an SEC Form 4 filing, demonstrates insider confidence in the nutritional …
Andersons Inc. (NASDAQ: ANDE) director Gary A. Douglas completed multiple security transactions on July 21 and 22, 2026, according to a disclosure filed with the Securities and Exchange Commission. The transactions included the acquisition of common stock through dividend reinvestment and the vesting of …
USANA Health Sciences, a leader in nutritional products, has disclosed recent stock transactions involving its director, Peggie Pelosi. This update highlights the acquisition and disposition of shares, which may be of interest to investors monitoring insider activity and ownership changes within the company.
USANA Health Sciences Inc. has disclosed a significant acquisition of restricted stock units by its director, Gilbert A. Fuller. This transaction, reported on July 27, 2026, highlights the ongoing commitment of company leadership to align their interests with those of shareholders. Investors may find …
USANA Health Sciences, a prominent player in the nutritional supplements market, has disclosed a notable stock transaction involving its director, Nixon J. Scott. The transaction, which took place on July 23, 2026, involves the acquisition of restricted stock units, raising interest among investors regarding …
Please wait processing your request...